Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00601055 · ClinicalTrials.gov registry record · NA

Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease

A NA study of Depression and Pulmonary Disease, Chronic Obstructive, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
101
Enrollment target
2
Study locations

NCT00601055 is a NA study of Depression and Pulmonary Disease, Chronic Obstructive that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 101 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00601055, a NA study of Depression and Pulmonary Disease, Chronic Obstructive, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
101 participants
Enrollment target
2
Study locations

Study Summary

This study will evaluate the effectiveness of problem-solving therapy combined with treatment adherence procedures in treating older people with major depression and chronic obstructive pulmonary disease.

Interventions

  • BEHAVIORAL Problem Solving-Rx Adherence (PSA)
  • BEHAVIORAL PID-C

Study Locations (2)

New York

  • The Burke Rehabilitation Hospital - White Plains
  • Weill Medical College of Cornell University - White Plains

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2008-02
Est. Completion 2015-08
Phase NA

What the Registry Record Tells You About NCT00601055

The ClinicalTrials.gov registry entry for NCT00601055 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Problem Solving-Rx Adherence (PSA) is the first listed.

NCT00601055 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00601055 about?

NCT00601055 is a clinical study titled "Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease". This study will evaluate the effectiveness of problem-solving therapy combined with treatment adherence procedures in treating older people with major depression and chronic obstructive pulmonary disease.

What is the current status of trial NCT00601055?

This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2008-02. Estimated completion is 2015-08.

What conditions does trial NCT00601055 study?

This clinical trial studies the following conditions: Depression, Pulmonary Disease, Chronic Obstructive.

What interventions are being tested in trial NCT00601055?

The interventions under investigation include: Problem Solving-Rx Adherence (PSA) (BEHAVIORAL), PID-C (BEHAVIORAL).

Who is sponsoring clinical trial NCT00601055?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00601055 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.